Free Trial
TSE:TH

Theratechnologies (TH) Stock Price, News & Analysis

Theratechnologies logo

About Theratechnologies Stock (TSE:TH)

Key Stats

Today's Range
N/A
50-Day Range
C$4.47
▼
C$4.47
52-Week Range
N/A
Volume
35,472 shs
Average Volume
75,081 shs
Market Capitalization
C$205.53 million
P/E Ratio
N/A
Dividend Yield
3.76%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TH Stock News Headlines

Theratechnologies Gains Support for Future Pak Acquisition
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
Theratechnologies Inc. (TH.TO)
See More Headlines

TH Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Theratechnologies investors own include ProMetic Life Sciences (PLI), Bristol Myers Squibb (BMY), Novo Nordisk A/S (NVO), ARC Resources (ARX), Alimentation Couche-Tard (ATD.B), Bombardier, Inc. Class B (BBD.B) and Keyera (KEY).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
TSE:TH
CIK
N/A
Fax
N/A
Employees
103
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-8.5
Net Income
-C$1.96 million
Net Margins
-9.67%
Pretax Margin
N/A
Return on Equity
36.00%
Return on Assets
5.15%

Debt

Debt-to-Equity Ratio
-180.46
Current Ratio
1.19
Quick Ratio
0.64

Sales & Book Value

Annual Sales
C$84.38 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.76
Book Value
C($0.51) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
45,980,000
Free Float
N/A
Market Cap
C$205.53 million
Optionable
Not Optionable
Beta
0.26
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (TSE:TH) was last updated on 9/26/2025 by MarketBeat.com Staff.
From Our Partners